Literature DB >> 17322450

RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation.

J Ristiniemi1, T Flinkkilä, P Hyvönen, M Lakovaara, H Pakarinen, P Jalovaara.   

Abstract

External fixation of distal tibial fractures is often associated with delayed union. We have investigated whether union can be enhanced by using recombinant bone morphogenetic protein-7 (rhBMP-7). Osteoinduction with rhBMP-7 and bovine collagen was used in 20 patients with distal tibial fractures which had been treated by external fixation (BMP group). Healing of the fracture was compared with that of 20 matched patients in whom treatment was similar except that rhBMP-7 was not used. Significantly more fractures had healed by 16 (p=0.039) and 20 weeks (p=0.022) in the BMP group compared with the matched group. The mean time to union (p=0.002), the duration of absence from work (p=0.018) and the time for which external fixation was required (p=0.037) were significantly shorter in the BMP group than in the matched group. Secondary intervention due to delayed healing was required in two patients in the BMP group and seven in the matched group. RhBMP-7 can enhance the union of distal tibial fractures treated by external fixation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17322450     DOI: 10.1302/0301-620X.89B2.18230

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  27 in total

Review 1.  Bone morphogenetic proteins and their antagonists: current and emerging clinical uses.

Authors:  Imran H A Ali; Derek P Brazil
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 2.  Clinical application of bone morphogenetic proteins for bone healing: a systematic review.

Authors:  Gopal Shankar Krishnakumar; Alice Roffi; Davide Reale; Elizaveta Kon; Giuseppe Filardo
Journal:  Int Orthop       Date:  2017-04-19       Impact factor: 3.075

Review 3.  Clinical translation of controlled protein delivery systems for tissue engineering.

Authors:  Kara L Spiller; Gordana Vunjak-Novakovic
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

Review 4.  BMP gene delivery for skeletal tissue regeneration.

Authors:  Maxim Bez; Gadi Pelled; Dan Gazit
Journal:  Bone       Date:  2020-05-21       Impact factor: 4.398

5.  Clinical application of recombinant human bone morphogenetic protein in cats and dogs: a review of 13 cases.

Authors:  Cory B Pinel; G Elizabeth Pluhar
Journal:  Can Vet J       Date:  2012-07       Impact factor: 1.008

6.  Open tibial fractures grade IIIC treated successfully with external fixation, negative-pressure wound therapy and recombinant human bone morphogenetic protein 7.

Authors:  Ireneusz Babiak
Journal:  Int Wound J       Date:  2012-11-19       Impact factor: 3.315

7.  In situ bone tissue engineering via ultrasound-mediated gene delivery to endogenous progenitor cells in mini-pigs.

Authors:  Maxim Bez; Dmitriy Sheyn; Wafa Tawackoli; Pablo Avalos; Galina Shapiro; Joseph C Giaconi; Xiaoyu Da; Shiran Ben David; Jayne Gavrity; Hani A Awad; Hyun W Bae; Eric J Ley; Thomas J Kremen; Zulma Gazit; Katherine W Ferrara; Gadi Pelled; Dan Gazit
Journal:  Sci Transl Med       Date:  2017-05-17       Impact factor: 17.956

8.  Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report.

Authors:  Sreevathsa Boraiah; Omesh Paul; David Hawkes; Matthew Wickham; Dean G Lorich
Journal:  Clin Orthop Relat Res       Date:  2009-08-20       Impact factor: 4.176

9.  Updates in biological therapies for knee injuries: bone.

Authors:  Mauricio Kfuri; Rafael Lara de Freitas; Bruno Bellaguarda Batista; Rodrigo Salim; Marcello Teixeira Castiglia; Ricardo Antonio Tavares; Paulo Henrique Araújo
Journal:  Curr Rev Musculoskelet Med       Date:  2014-09

Review 10.  Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion.

Authors:  Andrew P White; Alexander R Vaccaro; Jeremy A Hall; Peter G Whang; Brian C Friel; Michael D McKee
Journal:  Int Orthop       Date:  2007-07-25       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.